Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease
暂无分享,去创建一个
Lisa A. Weissfeld | William E. Klunk | Chester A. Mathis | Julie C. Price | Scott K. Ziolko | Steven T. DeKosky | Brian J. Lopresti | Jessica A. Hoge | S. DeKosky | W. Klunk | C. Mathis | J. Price | L. Weissfeld | B. Lopresti | J. Hoge | S. Ziolko | J. Price | J. Price
[1] H. Keselman,et al. Multiple Comparison Procedures , 2005 .
[2] Thomas E. Nichols,et al. Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.
[3] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] M. Bobinski,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[5] S. DeKosky,et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] C. C. Watson,et al. New, faster, image-based scatter correction for 3D PET , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).
[7] D. Selkoe,et al. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. , 1989, The American journal of pathology.
[8] Klaus Wienhard,et al. Applications of 3D PET , 1998 .
[9] Karl J. Friston,et al. Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] D. Townsend,et al. The Theory and Practice of 3D PET , 1998, Developments in Nuclear Medicine.
[11] Alan A. Wilson,et al. A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1) , 2004 .
[12] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[13] R. Katzman.,et al. Education and the prevalence of dementia and Alzheimer's disease , 1993, Neurology.
[14] Thomas E. Nichols,et al. Controlling the familywise error rate in functional neuroimaging: a comparative review , 2003, Statistical methods in medical research.
[15] S Minoshima,et al. An automated method for rotational correction and centering of three-dimensional functional brain images. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] N. Foster,et al. Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis , 1995, Journal of computer assisted tomography.
[17] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[18] Ralph Buchert,et al. Adjusted Scaling of FDG Positron Emission Tomography Images for Statistical Evaluation in Patients With Suspected Alzheimer's Disease , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[19] J. Baron,et al. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[20] W. Klunk,et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.
[21] S S Gambhir,et al. A tabulated summary of the FDG PET literature. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Tim D. Fryer,et al. Declarative memory impairments in Alzheimer's disease and semantic dementia , 2006, NeuroImage.
[23] D. Knopman,et al. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. , 2001, The American journal of managed care.
[24] William E. Klunk,et al. The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component , 2003, The Journal of Neuroscience.
[25] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[26] M. Ball,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories: Concurrences and Cautions , 1997, Neurobiology of Aging.
[27] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[28] S. Hirai,et al. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated byβ protein immunostain , 2004, Acta Neuropathologica.
[29] O L Lopez,et al. Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I , 2000, Neurology.
[30] Karl J. Friston,et al. A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.
[31] et al.,et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.
[32] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[34] Alan C. Evans,et al. A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] J. V. Haxby,et al. Spatial Pattern Analysis of Functional Brain Images Using Partial Least Squares , 1996, NeuroImage.
[36] A. King,et al. The question of familial meningiomas and schwannomas: , 2000, Neurology.
[37] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[38] John D. Storey. A direct approach to false discovery rates , 2002 .
[39] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[40] G Rodriguez,et al. Discrimination between Alzheimer patients and healthy people by qEEG and rCBF examinations , 1997 .
[41] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[42] Mary Ann Moran,et al. Synthesis and Evaluation , 1986 .
[43] A. Tamhane,et al. Multiple Comparison Procedures , 1989 .
[44] G. V. Van Hoesen,et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.
[45] S. Wisniewski,et al. Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II , 2000, Neurology.
[46] C. Bell. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 1994 .
[47] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[48] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[49] Brian J Bacskai,et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] D. Wolfe,et al. Nonparametric Statistical Methods. , 1974 .
[51] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[52] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[53] J. Baron,et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. , 1998, Brain : a journal of neurology.